Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
or
Menu

Pulse Biosciences CS (PLSE)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (BATS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ fieldTitles[key] ]] [[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 249,993
  • Shares Outstanding, K 16,880
  • Annual Sales, $ 0 K
  • Annual Income, $ -25,570 K
  • 36-Month Beta 1.96
  • Price/Sales N/A
  • Price/Cash Flow N/A
  • Price/Book 6.33

Price Performance

See More
Period Period Low Period High Performance
1-Month
14.02 +5.63%
on 07/10/18
17.41 -14.93%
on 06/14/18
-2.33 (-13.59%)
since 06/13/18
3-Month
14.02 +5.63%
on 07/10/18
22.20 -33.29%
on 05/08/18
-5.29 (-26.32%)
since 04/13/18
52-Week
9.81 +50.95%
on 09/13/17
34.82 -57.47%
on 11/10/17
-15.74 (-51.52%)
since 07/13/17

Most Recent Stories

More News
Pulse Biosciences to Report Second Quarter 2018 Financial Results and Operational Highlights

Pulse Biosciences, Inc. (Nasdaq: PLSE), a medical technology company developing a proprietary therapeutic tissue treatment based on its Nano-Pulse Stimulation (NPS) platform, today announced...

PLSE : 14.81 (-3.96%)
Pulse Biosciences Announces Treatment of First Patients in Study to Evaluate the Safety and Efficacy of Novel Nano-Pulse Stimulation for the Treatment of Sebaceous Hyperplasia Lesions

Pulse Biosciences, Inc. (Nasdaq: PLSE) today announced treatment of the first patients in its multicenter study to evaluate the safety and efficacy of its Nano-Pulse Stimulation (NPS) technology...

PLSE : 14.81 (-3.96%)
Robbins Arroyo LLP Is Investigating the Officers and Directors of Pulse Biosciences, Inc. (PLSE) on Behalf of Shareholders

Shareholder rights law firm Robbins Arroyo LLP is investigating whether certain officers and directors of Pulse Biosciences, Inc. (NasdaqCM: PLSE) breached their fiduciary duties to shareholders....

PLSE : 14.81 (-3.96%)
Pulse Biosciences Grants Equity Incentive Awards to New Employees

Pulse Biosciences, Inc. (NASDAQ: PLSE), a medical technology company developing a proprietary therapeutic tissue treatment based on its Nano-Pulse Stimulation (NPS) platform, announced today...

PLSE : 14.81 (-3.96%)
Kaskela Law LLC Announces Investigation of Pulse Biosciences, Inc. on Behalf of Stockholders

RADNOR, PA / ACCESSWIRE / June 20, 2018 / Kaskela Law LLC is investigating Pulse Biosciences, Inc. ("Pulse" or the "Company") (NASDAQ: PLSE) on behalf of the Company's stockholders. The investigation seeks...

PLSE : 14.81 (-3.96%)
Pulse Biosciences Quarterly Investor Conference Call

Pulse Biosciences, Inc. (Nasdaq: PLSE), a medical technology company developing a proprietary therapeutic tissue treatment based on its Nano-Pulse Stimulation platform, today reported recent...

PLSE : 14.81 (-3.96%)
Pulse Biosciences to Report First Quarter 2018 Financial Results and Operational Highlights

Pulse Biosciences, Inc. (Nasdaq: PLSE), a medical technology company developing a proprietary therapeutic tissue treatment based on its Nano-Pulse Stimulation (NPS) platform, today announced...

PLSE : 14.81 (-3.96%)
Pulse Biosciences Announces Positive Results from Its First Study Evaluating a Clinical Target at Major Scientific Meeting

--Dose-response study of clinical and histological effects of NPS energy in human skin wins Best of Basic Science and Translational Research Session Award

PLSE : 14.81 (-3.96%)
Pulse Biosciences Grants Equity Incentive Awards to New Employees

Pulse Biosciences, Inc. (NASDAQ: PLSE), a medical technology company developing a proprietary therapeutic tissue treatment based on its Nano-Pulse Stimulation (NPS) platform, today announced...

PLSE : 14.81 (-3.96%)
Pulse Biosciences Quarterly Investor Conference Call

Pulse Biosciences, Inc. (Nasdaq: PLSE), a medical technology company developing a proprietary therapeutic tissue treatment based on its Nano-Pulse Stimulation platform today reports recent...

PLSE : 14.81 (-3.96%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 72% Sell with a Average short term outlook on maintaining the current direction.

Longer term, the trend strength is Average. Long term indicators fully support a continuation of the trend.

See More Share

Trade PLSE with:

Business Summary

Pulse Biosciences, Inc. is a medical device company. It is engaged in developing a novel and proprietary tissue treatment platform using Nano-Pulse Electro-Signaling. NPES provide effective local tumor control and to initiate an adaptive immune response. The company deploy NPES platform applications...

See More

Key Turning Points

2nd Resistance Point 15.74
1st Resistance Point 15.27
Last Price 14.81
1st Support Level 14.54
2nd Support Level 14.28

See More

52-Week High 34.82
Fibonacci 61.8% 25.27
Fibonacci 50% 22.32
Fibonacci 38.2% 19.36
Last Price 14.81
52-Week Low 9.81

See More

Add Data Columns to this Table
Learn about our Custom Views
Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
New Chart Menu
Right-click anywhere on the chart to open the Interactive Chart menu.

Free Barchart Webinar